EndoChoice Holdings (GI) Getting Somewhat Favorable Press Coverage, Report Shows

News stories about EndoChoice Holdings (NYSE:GI) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. EndoChoice Holdings earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned headlines about the medical equipment provider an impact score of 47.2043347544338 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

EndoChoice Holdings (NYSE:GI) remained flat at $8.00 during midday trading on Tuesday. 14,076 shares of the company’s stock traded hands. The firm’s 50-day moving average is $8.00 and its 200-day moving average is $7.14. EndoChoice Holdings has a one year low of $3.64 and a one year high of $8.03.

TRADEMARK VIOLATION NOTICE: “EndoChoice Holdings (GI) Getting Somewhat Favorable Press Coverage, Report Shows” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://ledgergazette.com/2017/10/10/endochoice-holdings-gi-getting-somewhat-favorable-press-coverage-report-shows.html.

About EndoChoice Holdings

EndoChoice Holdings, Inc is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Receive News & Ratings for EndoChoice Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EndoChoice Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply